Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial.
Saved in:
| Title: | Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. |
|---|---|
| Authors: | Ghasabeh AS; Laboratory Hematology and Blood Bank Department, School of Allied Medical Science, Shahid Beheshti University of Medical Science, Tehran, Iran., Izadpanah A; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Bakhtiyaridovvombaygi M; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Student Research Committee, Laboratory Hematology and Blood Bank Department, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Seresht-Ahmadi M; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Parkhideh S; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Seraji HR; Department of Hematology and Oncology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Sabri A; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Yazdanparast S; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran., Hajifathali A; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. hajifathali@yahoo.com., Gharehbaghian A; Laboratory Hematology and Blood Bank Department, School of Allied Medical Science, Shahid Beheshti University of Medical Science, Tehran, Iran. gharehbaghian@hotmail.com., Roshandel E; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. elham.roshandel@gmail.com. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Mar 31; Vol. 75 (4). Date of Electronic Publication: 2026 Mar 31. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41915180 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ghasabeh+AS%22">Ghasabeh AS</searchLink>; Laboratory Hematology and Blood Bank Department, School of Allied Medical Science, Shahid Beheshti University of Medical Science, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Izadpanah+A%22">Izadpanah A</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Bakhtiyaridovvombaygi+M%22">Bakhtiyaridovvombaygi M</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Student Research Committee, Laboratory Hematology and Blood Bank Department, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Seresht-Ahmadi+M%22">Seresht-Ahmadi M</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Parkhideh+S%22">Parkhideh S</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Seraji+HR%22">Seraji HR</searchLink>; Department of Hematology and Oncology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Sabri+A%22">Sabri A</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Yazdanparast+S%22">Yazdanparast S</searchLink>; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.<br /><searchLink fieldCode="AU" term="%22Hajifathali+A%22">Hajifathali A</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. hajifathali@yahoo.com.<br /><searchLink fieldCode="AU" term="%22Gharehbaghian+A%22">Gharehbaghian A</searchLink>; Laboratory Hematology and Blood Bank Department, School of Allied Medical Science, Shahid Beheshti University of Medical Science, Tehran, Iran. gharehbaghian@hotmail.com.<br /><searchLink fieldCode="AU" term="%22Roshandel+E%22">Roshandel E</searchLink>; Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. elham.roshandel@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228605732%22">Cancer immunology, immunotherapy : CII</searchLink> [Cancer Immunol Immunother] 2026 Mar 31; Vol. 75 (4). <i>Date of Electronic Publication: </i>2026 Mar 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>8605732 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0851 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203407004%22">03407004 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Immunol Immunother <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41915180 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00262-025-04285-9 Languages: – Code: eng Text: English Titles: – TitleFull: Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ghasabeh AS – PersonEntity: Name: NameFull: Izadpanah A – PersonEntity: Name: NameFull: Bakhtiyaridovvombaygi M – PersonEntity: Name: NameFull: Seresht-Ahmadi M – PersonEntity: Name: NameFull: Parkhideh S – PersonEntity: Name: NameFull: Seraji HR – PersonEntity: Name: NameFull: Sabri A – PersonEntity: Name: NameFull: Yazdanparast S – PersonEntity: Name: NameFull: Hajifathali A – PersonEntity: Name: NameFull: Gharehbaghian A – PersonEntity: Name: NameFull: Roshandel E IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 03 Text: 2026 Mar 31 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0851 Numbering: – Type: volume Value: 75 – Type: issue Value: 4 Titles: – TitleFull: Cancer immunology, immunotherapy : CII Type: main |
| ResultId | 1 |
